Dendritic cells (DCs) are considered the most potent antigen-presenting cells (APCs), which directly prime or cross-prime MHC I-restricted cytotoxic T cells (CTLs). However, recent evidence suggests the existence of other, as-yet unidentified APCs also able to prime T cells. To identify those APCs, we used adenoviral (rAd) vectors, which do not infect DCs but selectively accumulate in CD169 + macrophages (MPs). In mice that lack DCs, infection of CD169 + MPs was sufficient to prime CTLs specific for all epitopes tested. In contrast, CTL responses relying exclusively on cross-presenting DCs were biased to selected strong MHC I-binding peptides only. When both DCs and MPs were absent, no CTL responses could be elicited. Therefore, CD169+ MPs can be considered APCs that significantly contribute to CTL responses. + T cells (4). In contrast, MPs are considered cells of the innate immune system that limit pathogen spread by phagocytosis and degradation. They are positioned at strategically important entry points, such as the subcapsular sinus of lymph nodes and the marginal zone and red pulp areas of the spleen, where they capture and filter pathogens (5). Along with producing type I IFN (6), CD169+ marginal zone metallophilic MPs allow restricted replication of captured virus to increase the local availability of viral Ag (7) for transfer to B cells for humoral responses (8) and to DCs for cross-priming of CD8 + T cells (9). Participation of MPs in T-cell priming is thought to be restricted to Ag acquisition, amplification, and redistribution.Analyzing MP functions in vivo is difficult; genetic models, such as the CD11c-diphteria toxin (DT) receptor (DTR) transgenic mice (2), cannot make the distinction, because both DCs and monocytes/MPs are equally deleted on DT treatment (10, 11). Recent results with mice lacking CD169 + MPs suggest the role of these MPs in cross-priming of CD8 + T cells specific for the cell-associated model Ag ovalbumin (OVA) in lymph nodes (12). These findings are in contrast with another study in which MPs were unable to cross-present soluble OVA protein in mice lacking DCs (11). Although cross-presentation by DCs is now thought to allow priming of cytotoxic T-cell responses to exogenous tumor or viral Ag (4), the importance of cross-presentation in vivo has been a matter of intense debate over the last decade (13). Although this debate remains unresolved, cross-presentation has been considered then and now to be an exception rather than a rule (14,15).To determine the roles of MPs and DCs, we used a mouse model that specifically lacks DCs but conserves all subpopulations of MPs. We show that the presence of directly infected CD169 + MPs is sufficient to prime CTLs, including those recognizing epitopes not covered by cross-presenting DCs. In contrast, when only DCs cross-prime CTLs without the participation of MPs, the CTL repertoire is incomplete and biased toward the few peptides that interact strongly with MHCI. Our data demonstrate a division of labor between CD169 + MPs and DCs in situati...